Sientra, which is based in Santa Barbara, Calif., said its implants are available in a broad selection of sizes, profiles, projections, and implant surfaces.
“We are elated to receive FDA approval of our flagship portfolio of silicone breast implants,” said Hani Zeini, founder and CEO of Sientra, in the release. “This represents two significant milestones. Namely, for the first time in 20 years, Sientra has successfully broken the existing duopoly in the U.S. by offering surgeons and patients a new choice. And today, Sientra becomes the first and only company in the U.S. to provide a full portfolio of commercially-available breast implants, including shaped implants in addition to standard round implants.”
Related Articles on FDA Clearances and Approvals:
FDA Provides 510(k) Clearance for Software Modifications to STERIS System 1E Sterilization Device
FDA Approves FluMist Quadrivalent for Flu Vaccination
FDA Might Approve First Weight Loss Drug in More Than a Decade
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.